Financial News
Biolase, Inc. - Common Stock (NQ:BIOL)
All News about Biolase, Inc. - Common Stock

Earnings Preview For Biolase
March 20, 2024
Via Benzinga


Via Benzinga


Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
February 20, 2024
Via ACCESSWIRE

BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
February 15, 2024
Via ACCESSWIRE

A Preview Of Biolase's Earnings
November 08, 2023
Via Benzinga


Nasdaq Down Over 2%; Marriott Earnings Top Views
February 13, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities

12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via Benzinga

Gold Down Over 1%; Coca-Cola Posts Upbeat Sales
February 13, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities


Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January
February 13, 2024
Via Benzinga

BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
February 13, 2024
Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's After-Market Session
February 09, 2024
Via Benzinga


12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session
January 02, 2024
Via Benzinga


12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 06, 2023
Via Benzinga




12 Health Care Stocks Moving In Friday's Pre-Market Session
November 10, 2023
Via Benzinga


12 Health Care Stocks Moving In Thursday's After-Market Session
November 09, 2023
Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 08, 2023
Via Benzinga


12 Health Care Stocks Moving In Wednesday's Intraday Session
September 20, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.